Amgen Pays $240m for Michigan Spinoff’s Dendritic Cell Targeting Molecules for Autoimmune Disorders
January 14, 2021
The multinational biopharmaceutical company Amgen has announced it will pay $240 million in upfront cash and milestone payments for molecules targeting autoimmune conditions from Ann Arbor, MI-based Evoq Therapeutics, a spinoff of research from the University of Michigan. Evoq, founded by Profs. Anna Schwendeman and James Moon, is named for the targeted dendritic cells the company uses to “evoke” immune tolerance in regulatory T cells.
Read more about the pair’s research and their new partnership with Amgen.
Latest News
From Student Support to Endowed Legacy
June 22, 2026
Allen J. Sedman, PhD ’73, MD ’78, and Aileen B. Sedman, MD ’78, have spent their lives utilizing the knowledge imparted by the University of Michigan. In turn, they have expressed their gratitude through gifts bestowed to the College of Pharmacy and the Department of Pediatrics.
Allen Sedman arrived at U-M at a time when pharmacokinetics […]
Sharma’s Mission: Precision Drug Development to Meet Unmet Needs
June 15, 2026
Rare eye conditions that slowly destroy vision. Brain injuries and degenerative neurological diseases beyond the reach of many drugs. These are some of the disease areas that Anjali Sharma, PhD, will target with her drug delivery research when she joins the College of Pharmacy Department of Pharmaceutical Sciences as an Associate Professor with tenure in […]
Honoring a Legacy of Innovation, Leadership and Compassion: Remembering Dr. Hae Mi Choe
June 1, 2026
The legacy of Dr. Hae Mi Choe continues to shape the future of pharmacy, through the lives she touched, the systems she transformed and the enduring recognition of her extraordinary contributions.
Dr. Choe, who passed away on July 12, 2025, following a courageous battle with leukemia, was a visionary leader, mentor and innovator whose influence extended […]